亚马逊导购/好书推荐 
卑诗省当天新盘 
读新闻学外语
唐纳德·特朗普总统大力宣传一项新的行政命令，该命令将使美国药品价格与欧洲和英国的药品价格更加一致，为数百万美国人使用的药品降低价格打开了大门。
该行政命令并未具体说明哪些药品将成为目标，但特朗普在2020年提出的类似政策也涵盖了在联邦医疗保险B部分下在医院或诊所使用的药品，该部分涵盖老年人的住院药品。然而，该政策被一名联邦法官否决，他裁定政府绕过国会，超越了其权限。
2020年的那项提案仅涵盖了联邦医疗保险B部分的药品，包括老年人使用的免疫抑制剂、化疗药物和疫苗。新的行政命令似乎涵盖范围更广，提到了“美国患者”以及“公共和私人支付者”。
美国药品价格比其他发达国家高出三到五倍，人均花费是其他富裕国家的两倍——美国平均963美元，而其他国家平均466美元。
特朗普谈到这项新政策时表示：“这叫做最惠国待遇。我们将支付世界上最低的价格。谁付的价最低；那就是我们要得到的价格。”
唐纳德·特朗普总统长期鼓吹的最惠国政策旨在通过迫使制药公司向美国人提供与其他富裕国家相同的大幅折扣来大幅降低美国药品价格。
该提案在实施前必须得到国会议员的批准，预计大型制药公司将进行游说反对该政策，并在该政策颁布后提起诉讼以阻止其实施。
President Donald Trump touted a new executive order that would more closely align drug prices in the US with those sold in Europe and the UK, opening the door for drugs used by millions of Americans to become cheaper.
The EO does not specify which drugs will be targeted but a similar policy proposed by Trump in 2020 included drugs administered in hospitals or clinics under Medicare Part B, which covers inpatient drugs for seniors. However, that policy was blocked by a federal judge who ruled the government had overstepped its bounds by sidestepping Congress.
That 2020 proposal narrowly covered Medicare Part B drugs, including immunosuppressants, chemotherapy, and vaccines for seniors. The new EO appears broader, referencing ‘American patients’ and ‘public and private payers.’
US drug prices are three to five times higher than in other developed nations, with per-person spending double that of other wealthy countries – $963 in the US versus $466 on average elsewhere.
‘It’s called Most Favored Nation,’ Trump said of the new policy. ‘We’re going to pay the lowest price there is in the world. We will get, whoever is paying the lowest price; that’s the price that we’re going to get.’
The Most Favored Nation policy long touted by President Donald Trump is designed to slash US drug prices by forcing pharmaceutical companies to offer Americans the same steep discounts they give other wealthy nations.
Before being implemented, the proposal would have to be approved by the members of Congress and Big Pharma is expected to lobby against the policy and sue to block it if it’s enacted.
